Biomarkers for sepsis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Henriquez Camacho, Cesar ^a   Losa, Juan ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PRESEPSIN; PROADRENOMEDULLIN; PROCALCITONIN; PROTEIN; SOLUBLE UROKINASE TYPE PLASMINOGEN RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG; CALCITONIN; PROTEIN PRECURSOR;

ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; HUMAN; INFLAMMATION; LOWER RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFECTION; SEPSIS; BLOOD;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; HUMANS; PROTEIN PRECURSORS; SEPSIS;

EID: 84899498326     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/547818     Document Type: Article

References (50)

1. Reinhart K., Bauer M., Riedemann N. C., Hartog C. S., New approaches to sepsis: molecular diagnostics and biomarkers. Clinical Microbiology Reviews 2012 25 4 609 634 10.1128/CMR.00016-12
2. Vincent J. L., Sakr Y., Sprung C. L., Ranieri V. M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J. R., Payen D., Sepsis in European intensive care units: results of the SOAP study. Critical Care Medicine 2006 34 2 344 353 2-s2.0-31344461826 10.1097/01.CCM.0000194725.48928.3A (Pubitemid 43145611)
3. Jones G. R., Lowes J. A., The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. Monthly Journal of the Association of Physicians 1996 89 7 515 522 2-s2.0-0030036693 (Pubitemid 26245392)
4. Balk R., Roger C., Bone, MD and the evolving paradigms of sepsis. Contributions to Microbiology 2011 17 1 11 2-s2.0-79959269975 10.1159/000323970
5. Faix J., Biomarkers of sepsis. Critical Reviews in Clinical Laboratory Sciences 2013 50 1 23 36 10.3109/10408363.2013.764490
6. Bates D. W., Sands K., Miller E., Lanken P. N., Hibberd P. L., Graman P. S., Schwartz J. S., Kahn K., Snydman D. R., Parsonnet J., Moore R., Black E., Johnson B. L., Jha A., Platt R., Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. Journal of Infectious Diseases 1997 176 6 1538 1551 2-s2.0-0030699238
7. Dupuy A., Philippart F., Pean Y., Lasocki S., Charles P., Chalumeau M., Claessens Y., Quenot J., Gras-Le Guen C., Ruiz S., Role of biomarkers in the management of antibiotic therapy: an expert panel review. I: currently available biomarkers for clinical use in acute infections. Annals of Intensive Care 2013 3 22, article 1 10.1186/2110-5820-3-1
8. Samraj R. S., Zingarelli B., Wong H. R., Role of biomarkers in sepsis care. Shock 2013 40 5 358 365
9. Pierrakos C., Vincent J. L., Sepsis biomarkers: a review. Critical Care 2010 14 1, article R15 2-s2.0-77956628404 10.1186/cc8872
10. Karzai W., Oberhoffer M., Meier-Hellmann A., Reinhart K., Procalcitonin-a new indicator of the systemic response to severe infections. Infection 1997 25 6 329 334 2-s2.0-0030660194 (Pubitemid 27507299)
11. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M., Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine 2001 345 19 1368 1377 2-s2.0-0035829842 10.1056/NEJMoa010307
12. Jaye D. L., Waites K. B., Clinical applications of C-reactive protein in pediatrics. Pediatric Infectious Disease Journal 1997 16 8 735 747 2-s2.0-0030804837 10.1097/00006454-199708000-00003 (Pubitemid 27364784)
13. Hofer N., Zacharias E., Müller W., Resch B., An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012 102 1 25 36 2-s2.0-84859701695 10.1159/000336629
14. Gilbert D. N., Use of plasma procalcitonin levels as an adjunct to clinical microbiology. Journal of Clinical Microbiology 2010 48 7 2325 2329 2-s2.0-77954438685 10.1128/JCM.00655-10
15. Limper M., de Kruif M. D., Duits A. J., Brandjes D. P. M., van Gorp E. C. M., The diagnostic role of Procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. Journal of Infection 2010 60 6 409 416 2-s2.0-77953322360 10.1016/j.jinf.2010.03.016
16. Billeter A., Turina M., Seifert B., Mica L., Stocker R., Keel M., Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World Journal of Surgery 2009 33 3 558 566 2-s2.0-60449088899 10.1007/s00268-008-9896-y
17. Schuetz P., Albrich W., Mueller B., Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine 2011 9, article 107 2-s2.0-80053173738 10.1186/1741-7015-9-107
18. Vincent J., Beumier M., Diagnostic and prognostic markers in sepsis. Expert Review of Anti-Infective Therapy 2013 11 3 265 275
19. Manian F. A., Use of procalcitonin to guide duration of antimicrobial therapy in intensive care units: proceed with caution. Clinical Infectious Diseases 2012 54 4 578 579 2-s2.0-84856695336 10.1093/cid/cir888
20. Li H., Luo Y. F., Blackwell T. S., Xie C. M., Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections. Antimicrobial Agents and Chemotherapy 2011 55 12 5900 5906 2-s2.0-81555206676 10.1128/AAC.00335-11
21. Schuetz P., Muller B., Christ M., Stolz D., Tamm M., Bouadma L., Luyt C., Wolff M., Chastre J., Tubach F., Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systemic Reviews 2012 9 CD007498 10.1002/14651858.CD007498.pub2
22. Prkno A., Wacker C., Brunkhorst F., Schlattmann P., Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock-systematic review and meta-analysis. Critical Care 2013 17 article R291
23. Schuetz P., Albrich W., Christ-Crain M., Chastre J., Mueller B., Procalcitonin for guidance of antibiotic therapy. Expert Review of Anti-Infective Therapy 2010 8 5 575 587 2-s2.0-77952279123 10.1586/eri.10.25
24. Quenot J. P., Luyt C. E., Roche N., Chalumeau M., Charles P. E., Claessens Y. E., Lasocki S., Bedos J. P., Péan Y., Philippart F., Ruiz S., Gras-Leguen C., Dupuy A. M., Pugin J., Stahl J. P., Misset B., Gauzit R., Brun-Buisson C., Role of biomakers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy. Annals of Intensive Care 2013 3 1, article 21 10. 1186/2110-5820-3-21
25. Phillips R. S., Wade R., Lehrnbecher T., Stewart L. A., Sutton A. J., Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Medicine 2012 10, article 6 2-s2.0-84855894765 10.1186/1741-7015-10-6
26. Dou Y. H., Du J. K., Liu H. L., Shong X. D., The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagnostic Microbiology and Infectious Disease 2013 76 4 464 469 10.1016/j.diagmicrobio.2013.04.023
27. Schwarz S., Bertram M., Schwab S., Andrassy K., Hacke W., Serum procalcitonin levels in bacterial and abacterial meningitis. Critical Care Medicine 2000 28 6 1828 1832 2-s2.0-0033932745 (Pubitemid 30428738)
28. Yu C. W., Juan L. I., Hsu S. C., Chen C. K., Wu C. W., Lee C. C., Wu J. Y., Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. The American Journal of Emergency Medicine 2013 31 6 935 941 10.1016/j.ajem.2013.03.008
29. Simon L., Gauvin F., Amre D. K., Saint-Louis P., Lacroix J., Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clinical Infectious Diseases 2004 39 2 206 217 2-s2.0-3242810355 10.1086/421997 (Pubitemid 38971491)
30. Uzzan B., Cohen R., Nicolas P., Cucherat M., Perret G. Y., Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Critical Care Medicine 2006 34 7 1996 2003 2-s2.0-33745622134 10.1097/01.CCM.0000226413.54364.36 (Pubitemid 43982479)
31. Tang B. M., Eslick G. D., Craig J. C., McLean A. S., Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infectious Diseases 2007 7 3 210 217 2-s2.0-33847056146 10.1016/S1473-3099(07)70052-X (Pubitemid 46274517)
32. Wacker C., Prkno A., Brunkhorst F., Schlattmann P., Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. The Lancet Infectious Diseases 2013 13 5 426 435 10.1016/S1473-3099(12)70323-7
33. Lee H., Procalcitonin as a biomarker of infectious diseases. The Korean Journal of Internal Medicine 2013 28 3 285 291 10.3904/kjim.2013.28.3.285
34. Wu Y., Wang F., Fan X., Bao R., Bo L., Li J., Deng X., Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Critical Care 2012 16 6, article R229
35. Bopp C., Hofer S., Bouchon A., Zimmermann J. B., Martin E., Weigand M. A., Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. European Journal of Anaesthesiology 2009 26 6 504 507 2-s2.0-68849093438 10.1097/EJA.0b013e328329afca
36. Backes Y., van der Sluijs K., Mackie D., Tacke F., Koch A., Tenhunen J., Schultz M., Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review Intensive. Care Medicine 2012 38 9 1418 1428 10.1007/s00134-012-2613-1
37. Thunø M., MacHo B., Eugen-Olsen J., SuPAR: the molecular crystal ball. Disease Markers 2009 27 3-4 157 172 2-s2.0-73349125115 10.3233/DMA-2009-0657
38. Donadello K., Scolletta S., Taccone F. S., Covajes C., Santonocito C., Cortes D. O., Grazulyte D., Gottin L., Vincent J. L., Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients. Journal of Critical Care 2014 24 1 144 149
39. Eugen-Olsen J., Gustafson P., Sidenius N., Fischer T. K., Parner J., Aaby P., Gomes V. F., Lisse I., The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. International Journal of Tuberculosis and Lung Disease 2002 6 8 686 692 2-s2.0-0035992373 (Pubitemid 34832148)
40. Koch A., Voigt S., Kruschinski C., Sanson E., Dückers H., Horn A., Yagmur E., Zimmermann H., Trautwein C., Tacke F., Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical Care 2011 15 1, article R63 2-s2.0-79951557734 10.1186/cc10037
41. Loonen A. J., de Jager C. P., Tosserams J., Kusters R., Hilbink M., Wever P. C., van den Brule A. J., Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS ONE 2014 9 1 e87315 10.1371/journal.pone.0087315
42. Hinson J. P., Kapas S., Smith D. M., Adrenomedullin, a multifunctional regulatory peptide. Endocrine Reviews 2000 21 2 138 167 2-s2.0-0034453838 10.1210/er.21.2.138 (Pubitemid 32275593)
43. Struck J., Tao C., Morgenthaler N. G., Bergmann A., Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004 25 8 1369 1372 2-s2.0-4444356533 10.1016/j.peptides.2004.06.019 (Pubitemid 39180069)
44. Suberviola B., Castellanos-Ortega Á., Llorca J., Ortiz F., Iglesias D., Prieto B., Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia. Swiss Medical Weekly 2012 142 2-s2.0-84859501976 10.4414/smw.2012.13542 w13542
45. Suberviola B., Castellanos-Ortega A., Ruiz Ruiz A., Lopez-Hoyos M., Santibañez M., Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Medicine 2013 39 11 1945 1952 10.1007/s00134-013-3056-z
46. Angeletti S., Battistoni F., Fioravanti M., Bernardini S., Dicuonzo G., Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis. Clinical Chemistry and Laboratory Medicine 2013 51 5 1059 1067
47. Endo S., Suzuki Y., Takahashi G., Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy 2012 18 6 891 897 10.1007/s10156-012-0435-2
48. Ulla M., Pizzolato E., Lucchiari M., Loiacono M., Soardo F., Forno D., Morello F., Lupia E., Moiraghi C., Mengozzi G., Battista S., Diagnostic and prognostic value of Presepsin in the management of sepsis in the emergency department: a multicentre prospective study. Critical Care 2013 17 4, article R168
49. Masson S., Caironi P., Spanuth E., Thomae R., Panigada M., Sangiorgi G., Fumagalli R., Mauri T., Isgrò S., Fanizza C., Romero M., Tognoni G., Latini R., Gattinoni L., Presepsin, (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Critical Care 2014 18 1, article R6
50. Liu B., Chen Y. X., Yin Q., Zhao Y. Z., Li C. S., Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Critical Care 2013 17 5, article R244